22 Rosenberg, S. A. (1992 ). Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer. J. Clin. Oncol . 10:180 . 23 Jäger E, Jäger D, and Knuth A. (1999) CTL -defined cancer vaccines: Perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Met Rev . 18:143 -50. 24 Curran MA, Mantalvo W, Yagita H, et al. (2010) PD -1 and C TLA -4 combination blockade expands infiltrating T cells and reduces regulatory T can myeloid cells within B16 melanoma tumors. PNAS 107(9): 4275 -4280. 25 Mellman I, Coukos G, and Dranoff G. (2011) Cancer immunotherapy comes of age. Nature Rev . 480: 480-489. 26 Yamazaki K, Spruill G, Rhoderick J, et al. (1999 ) Small cell lung carcinomas express shared and private tumor antigens presented by HLA -A1 or HLA -A2. Cancer Res . 59:4642 . 27 Raez LE, Walker GR, Baldie P, et al. (2013) CD8 T cell response in a phase 1 stu dy of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum -chaperone gp96 -Ig-peptide complexes. Advances in Lung Cancer. 2(1):9 -18.